(Q46742263)

English

Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18289173

Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18289173

0 references

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

Chun-Hung Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18289173

Jui-Yen Huang

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18289173

Cheng-Hsin Ching

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18289173

Jih-Ing Chuang

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18289173

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18289173

Journal of Pineal Research

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18289173

44

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18289173

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18289173

205-213

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18289173

Parkinson's disease. First of two parts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Parkinson's disease: mechanisms and models

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

The insecticide target in the PSST subunit of complex I.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

MPP+ produces progressive neuronal degeneration which is mediated by oxidative stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

gamma-Tocopherol attenuates MPTP-induced dopamine loss more efficiently than alpha-tocopherol in mouse brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Melatonin and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Melatonin is a potent modulator of dopamine release in the retina

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Acute locomotor effects of fluoxetine, sertraline, and nomifensine in young versus aged Fischer 344 rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Increase in dopamine release from the nucleus accumbens in response to feeding: a model to study interactions between drugs and naturally activated dopaminergic neurons in the rat brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Relationships between Lewy bodies and pale bodies in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Presymptomatic compensation in Parkinson's disease is not dopamine-mediated

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Naltrexone does not prevent the weight gain and hyperphagia induced by the antipsychotic drug sulpiride in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Non-invasive imaging of neuropathology in a rat model of alpha-synuclein overexpression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Mice lacking alpha-synuclein are resistant to mitochondrial toxins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Melatonin protects SK-N-SH neuroblastoma cells from amphetamine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Circadian-dependent effect of melatonin on dopaminergic D2 antagonist-induced hypokinesia and agonist-induced stereotypies in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Melatonin effects on behavior: possible mediation by the central GABAergic system.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00510.X

21 January 2018

Identifiers

10.1111/J.1600-079X.2007.00510.X

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18289173

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18289173

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46742263&oldid=2129540743"